vs
Anteris Technologies Global Corp.（AVR）与Inogen Inc（INGN）财务数据对比。点击上方公司名可切换其他公司
Inogen Inc的季度营收约是Anteris Technologies Global Corp.的221.2倍（$68.6M vs $310.0K）。Inogen Inc自由现金流更多（$-1.9M vs $-18.9M）
Anteris Technologies Global Corp是一家专注于结构性心脏病诊疗解决方案的医疗科技企业，开发及商业化生物假体心脏瓣膜、经导管介入产品，服务北美、欧洲及亚太地区的医疗机构，核心业务覆盖心脏外科与介入心脏病学领域。
Inogen Inc是一家专注于呼吸医疗设备领域的医疗科技企业，主要研发、生产和销售便携式制氧机及配套呼吸护理产品，面向北美、欧洲等地区需要长期氧疗的慢性呼吸系统疾病患者，服务居家及出行场景，提升用户生活质量。
AVR vs INGN — 直观对比
营收规模更大
INGN
是对方的221.2倍
$310.0K
自由现金流更多
INGN
多$17.0M
$-18.9M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $310.0K | $68.6M |
| 净利润 | $-29.2M | — |
| 毛利率 | 70.6% | 51.4% |
| 营业利润率 | -9343.5% | -13.6% |
| 净利率 | -9420.0% | — |
| 营收同比 | — | 3.4% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.74 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVRINGN
| Q4 25 | $310.0K | $68.6M | ||
| Q3 25 | $429.0K | $79.1M | ||
| Q2 25 | $618.0K | $79.2M | ||
| Q1 25 | $556.0K | $68.5M | ||
| Q4 24 | — | $66.3M | ||
| Q3 24 | — | $74.9M | ||
| Q2 24 | — | $74.4M | ||
| Q1 24 | — | $63.1M |
净利润AVRINGN
| Q4 25 | $-29.2M | — | ||
| Q3 25 | $-22.2M | $-5.3M | ||
| Q2 25 | $-20.8M | $-4.2M | ||
| Q1 25 | $-21.9M | $-6.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-14.6M |
毛利率AVRINGN
| Q4 25 | 70.6% | 51.4% | ||
| Q3 25 | 71.3% | 52.2% | ||
| Q2 25 | 76.1% | 52.2% | ||
| Q1 25 | 62.8% | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% | ||
| Q1 24 | — | 54.5% |
营业利润率AVRINGN
| Q4 25 | -9343.5% | -13.6% | ||
| Q3 25 | -5190.0% | -9.0% | ||
| Q2 25 | -3379.3% | -7.7% | ||
| Q1 25 | -3917.3% | -11.2% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | -10.4% | ||
| Q2 24 | — | -9.5% | ||
| Q1 24 | — | -25.8% |
净利率AVRINGN
| Q4 25 | -9420.0% | — | ||
| Q3 25 | -5185.1% | -6.7% | ||
| Q2 25 | -3371.2% | -5.2% | ||
| Q1 25 | -3932.4% | -9.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | — | -23.1% |
每股收益（稀释后）AVRINGN
| Q4 25 | $-0.74 | $-0.26 | ||
| Q3 25 | $-0.62 | $-0.20 | ||
| Q2 25 | $-0.58 | $-0.15 | ||
| Q1 25 | $-0.61 | $-0.25 | ||
| Q4 24 | — | $-0.41 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.24 | ||
| Q1 24 | — | $-0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $103.7M |
| 总债务越低越好 | $22.0K | — |
| 股东权益账面价值 | $-93.0K | $192.2M |
| 总资产 | $23.0M | $298.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVRINGN
| Q4 25 | — | $103.7M | ||
| Q3 25 | — | $106.5M | ||
| Q2 25 | — | $103.7M | ||
| Q1 25 | $49.0M | $118.9M | ||
| Q4 24 | — | $113.8M | ||
| Q3 24 | — | $105.7M | ||
| Q2 24 | — | $97.9M | ||
| Q1 24 | — | $107.4M |
总债务AVRINGN
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AVRINGN
| Q4 25 | $-93.0K | $192.2M | ||
| Q3 25 | $3.7M | $197.2M | ||
| Q2 25 | $24.4M | $199.5M | ||
| Q1 25 | $43.3M | $198.0M | ||
| Q4 24 | — | $173.9M | ||
| Q3 24 | — | $185.4M | ||
| Q2 24 | — | $187.6M | ||
| Q1 24 | — | $191.9M |
总资产AVRINGN
| Q4 25 | $23.0M | $298.6M | ||
| Q3 25 | $19.1M | $307.0M | ||
| Q2 25 | $39.9M | $312.0M | ||
| Q1 25 | $58.8M | $308.4M | ||
| Q4 24 | — | $296.2M | ||
| Q3 24 | — | $306.2M | ||
| Q2 24 | — | $308.9M | ||
| Q1 24 | — | $315.6M |
负债/权益比AVRINGN
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.5M | $-943.0K |
| 自由现金流经营现金流 - 资本支出 | $-18.9M | $-1.9M |
| 自由现金流率自由现金流/营收 | -6104.5% | -2.8% |
| 资本支出强度资本支出/营收 | 128.1% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-79.8M | $-13.7M |
8季度趋势，按日历期对齐
经营现金流AVRINGN
| Q4 25 | $-18.5M | $-943.0K | ||
| Q3 25 | $-18.3M | $2.2M | ||
| Q2 25 | $-19.5M | $4.3M | ||
| Q1 25 | $-21.5M | $-16.8M | ||
| Q4 24 | — | $-3.0M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $-4.7M |
自由现金流AVRINGN
| Q4 25 | $-18.9M | $-1.9M | ||
| Q3 25 | $-19.0M | $1.6M | ||
| Q2 25 | $-20.1M | $3.7M | ||
| Q1 25 | $-21.7M | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
自由现金流率AVRINGN
| Q4 25 | -6104.5% | -2.8% | ||
| Q3 25 | -4434.5% | 2.0% | ||
| Q2 25 | -3247.9% | 4.6% | ||
| Q1 25 | -3909.5% | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
资本支出强度AVRINGN
| Q4 25 | 128.1% | 1.4% | ||
| Q3 25 | 180.0% | 0.7% | ||
| Q2 25 | 86.9% | 0.9% | ||
| Q1 25 | 44.6% | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 2.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
